ISSN 2996-8968
Vol. 6, Issue 3, 2015October 01, 2016 EDT
Recent confusion and ongoing actions related to the FDA’s Inactive Ingredient Database (IID) - What should be included in the ANDA?
Recent confusion and ongoing actions related to the FDA’s Inactive Ingredient Database (IID) - What should be included in the ANDA?
Articles in Vol. 6, Issue 3, 2015
Vol. 6, Issue 3, 2015
- Recent confusion and ongoing actions related to the FDA’s Inactive Ingredient Database (IID) - What should be included in the ANDA?David R. Schoneker
- United States Pharmacopeia-National FormularyR. Christian Moreton
- The development of cracks on delayed release film of hygroscopic cores: A review of the tablet and coating formulations, coating processes and storage conditionsManjurul KaderJiben Roy
- The effect of thermal and chemical modifications of excipients on the compressional properties of paracetamol tablet formulations including maize, cassava and sweet potato starches as filler-bindersMariam V LawalMichael A. OdeniyiOludele A. Itiola
Schoneker, David R. 2016. “Recent Confusion and Ongoing Actions Related to the FDA’s Inactive Ingredient Database (IID) - What Should Be Included in the ANDA?” International Journal of Pharmaceutical Excipients 6 (3). https://doi.org/10.66617/001c.924.